Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
T cells and autoimmune kidney disease.
Suárez-Fueyo A, Bradley SJ, Klatzmann D, Tsokos GC. Suárez-Fueyo A, et al. Among authors: klatzmann d. Nat Rev Nephrol. 2017 Jun;13(6):329-343. doi: 10.1038/nrneph.2017.34. Epub 2017 Mar 13. Nat Rev Nephrol. 2017. PMID: 28287110 Review.
Role of regulatory T cells in a new mouse model of experimental autoimmune myositis.
Allenbach Y, Solly S, Grégoire S, Dubourg O, Salomon B, Butler-Browne G, Musset L, Herson S, Klatzmann D, Benveniste O. Allenbach Y, et al. Among authors: klatzmann d. Am J Pathol. 2009 Mar;174(3):989-98. doi: 10.2353/ajpath.2009.080422. Epub 2009 Feb 13. Am J Pathol. 2009. PMID: 19218348 Free PMC article.
Regulatory T cells in the treatment of disease.
Sharabi A, Tsokos MG, Ding Y, Malek TR, Klatzmann D, Tsokos GC. Sharabi A, et al. Among authors: klatzmann d. Nat Rev Drug Discov. 2018 Nov;17(11):823-844. doi: 10.1038/nrd.2018.148. Epub 2018 Oct 12. Nat Rev Drug Discov. 2018. PMID: 30310234 Review.
Interleukin-2 and regulatory T cells in rheumatic diseases.
Kolios AGA, Tsokos GC, Klatzmann D. Kolios AGA, et al. Among authors: klatzmann d. Nat Rev Rheumatol. 2021 Dec;17(12):749-766. doi: 10.1038/s41584-021-00707-x. Epub 2021 Nov 2. Nat Rev Rheumatol. 2021. PMID: 34728817 Review.
Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial.
Humrich JY, Cacoub P, Rosenzwajg M, Pitoiset F, Pham HP, Guidoux J, Leroux D, Vazquez T, Riemekasten G, Smolen JS, Tsokos G, Klatzmann D. Humrich JY, et al. Among authors: klatzmann d. Ann Rheum Dis. 2022 Dec;81(12):1685-1694. doi: 10.1136/ard-2022-222501. Epub 2022 Aug 16. Ann Rheum Dis. 2022. PMID: 35973803 Clinical Trial.
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.
Grinberg-Bleyer Y, Saadoun D, Baeyens A, Billiard F, Goldstein JD, Grégoire S, Martin GH, Elhage R, Derian N, Carpentier W, Marodon G, Klatzmann D, Piaggio E, Salomon BL. Grinberg-Bleyer Y, et al. Among authors: klatzmann d. J Clin Invest. 2010 Dec;120(12):4558-68. doi: 10.1172/JCI42945. Epub 2010 Nov 22. J Clin Invest. 2010. PMID: 21099113 Free PMC article.
Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.
Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D, Tran TA, Bodaghi B, Musset L, Soumelis V, Klatzmann D, Cacoub P, Saadoun D. Geri G, et al. Among authors: klatzmann d. J Allergy Clin Immunol. 2011 Sep;128(3):655-64. doi: 10.1016/j.jaci.2011.05.029. Epub 2011 Jul 2. J Allergy Clin Immunol. 2011. PMID: 21724243
371 results